Glaxo to Invest Up to $1 Billion in CureVac Vaccine Pact

(Bloomberg) -- GlaxoSmithKline Plc agreed to work with Germany’s CureVac on as many as five novel mRNA vaccines that will target infectious diseases as Covid-19 prompts companies and governments to...